Upgrade to SI Premium - Free Trial

Keros Therapeutics (KROS)

11.32 +0.21 (1.89%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/11/26)

Latest Headlines

Form 4 Keros Therapeutics, Inc. For: Aug 17 Filed by: BIENAIME JEAN JACQUES August 27, 2026 7:02 PM - SEC Filing Form 4 Keros Therapeutics, Inc. For: Aug 18 Filed by: Tanini Annita August 20, 2026 4:10 PM - SEC Filing Form 4 Keros Therapeutics, Inc. For: Aug 18 Filed by: Lerner Lorena Raquel August 20, 2026 4:10 PM - SEC Filing Form 4 Keros Therapeutics, Inc. For: Aug 18 Filed by: Cho Esther August 20, 2026 4:10 PM - SEC Filing Form 4 Keros Therapeutics, Inc. For: Aug 18 Filed by: Newton Charles W. August 20, 2026 4:10 PM - SEC Filing Form 4 Keros Therapeutics, Inc. For: Aug 17 Filed by: BIENAIME JEAN JACQUES August 19, 2026 4:10 PM - SEC Filing Form 144 Keros Therapeutics, Inc. Filed by: Newton Charles W. August 18, 2026 4:11 PM - SEC Filing Form 3 Keros Therapeutics, Inc. For: Aug 04 Filed by: Tanini Annita August 13, 2026 4:14 PM - SEC Filing Keros Therapeutics (KROS) PT Lowered to $18 at Wells Fargo August 4, 2026 8:06 AM - StreetInsider H.C. Wainwright Reiterates Buy Rating on Keros Therapeutics (KROS) August 4, 2026 6:53 AM - StreetInsider Keros Therapeutics (KROS) Misses Q2 EPS by 5c August 3, 2026 4:47 PM - StreetInsider Form 8-K Keros Therapeutics, Inc. For: Aug 03 August 3, 2026 4:08 PM - SEC Filing Form 10-Q Keros Therapeutics, Inc. For: Jun 30 August 3, 2026 4:03 PM - SEC Filing Form 8-K Keros Therapeutics, Inc. For: Aug 03 August 3, 2026 4:02 PM - SEC Filing Keros Therapeutics Reports Second Quarter 2026 Financial Results August 3, 2026 4:01 PM - Globe NewsWire Form 8-K Keros Therapeutics, Inc. For: Jul 30 July 30, 2026 4:02 PM - SEC Filing Keros Therapeutics to receive $20M milestone from Takeda July 30, 2026 4:01 PM - StreetInsider Keros Therapeutics to Receive Development Milestone Payment from Partner Takeda July 30, 2026 4:01 PM - Globe NewsWire Form SCHEDULE 13G/A Keros Therapeutics, Inc. Filed by: BlackRock, Inc. July 29, 2026 3:22 PM - SEC Filing Keros Therapeutics CFO resigns, interim finance chief named July 22, 2026 4:05 PM - StreetInsider Form 8-K Keros Therapeutics, Inc. For: Jul 17 July 22, 2026 4:01 PM - SEC Filing Form 4 Keros Therapeutics, Inc. For: Jul 15 Filed by: BIENAIME JEAN JACQUES July 17, 2026 4:10 PM - SEC Filing Form SCHEDULE 13G Keros Therapeutics, Inc. Filed by: BlackRock Portfolio Management LLC July 17, 2026 11:34 AM - SEC Filing Form 4 Keros Therapeutics, Inc. For: Jul 01 Filed by: Prener Anne July 6, 2026 4:31 PM - SEC Filing Form 3 Keros Therapeutics, Inc. For: Jul 01 Filed by: Prener Anne July 6, 2026 4:27 PM - SEC Filing Form 8-K Keros Therapeutics, Inc. For: Jun 23 June 25, 2026 4:02 PM - SEC Filing Keros Therapeutics names Anne Prener to its board of directors June 25, 2026 4:01 PM - StreetInsider Keros Therapeutics Appoints Anne Prener to its Board of Directors June 25, 2026 4:01 PM - Globe NewsWire Form 4 Keros Therapeutics, Inc. For: Jun 15 Filed by: BIENAIME JEAN JACQUES June 17, 2026 4:56 PM - SEC Filing Form 4 Keros Therapeutics, Inc. For: Jun 11 Filed by: Newton Charles W. June 15, 2026 4:16 PM - SEC Filing Form 144 Keros Therapeutics, Inc. Filed by: Newton Charles W. June 11, 2026 4:15 PM - SEC Filing Full Article List